Clinical Trial Update: Prospective Feasibility Pilot Study Evaluating the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) at Diagnosis and Disease Progression [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 feasibility trial evaluating 68Ga-PENTIXAFOR PET-CT imaging for CXCR4 targeting in metastatic small cell lung cancer at diagnosis and progressi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• 68Ga-Pentixafor

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Small Cell Lung Carcinoma (SCLC) | EARLY_Phase 1 | Status: NOT_YET_RECRUITING